In sum, there is evidence for a role for CD2AP in Aβ toxicity and pathology, but which cell types are reliant on CD2AP and how exactly CD2AP regulates Aβ biology in specific models of amyloidosis and AD remain to be fully investigated (see Fig. 2). This evidence concerns the gene CD2AP and Alzheimer disease.